Clinical Trials Directory

Trials / Completed

CompletedNCT02472457

Crohn Disease Exclusion Diet After Single Medication De-escalation

Biologic and Immunomodulator Withdrawal in Pediatric Crohn Disease With Deep Clinical Remission Using the Crohn Disease Exclusion Diet

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
Children's Hospital of Philadelphia · Academic / Other
Sex
All
Age
10 Years – 21 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to determine whether pediatric Crohn Disease (CD) patients in long-standing remission remain in remission longer after stopping medications if they follow the Crohn's Disease Exclusion Diet (CDED). The hypothesis is that subjects on the CDED will have longer time-to-relapse as opposed to those on an unrestricted diet.

Detailed description

Crohn disease (CD) is an idiopathic, chronic, relapsing and remitting inflammatory condition of the gastrointestinal tract with a high risk for complications and need for surgical interventions, particularly in children. Immunomodulators and biologic therapies are effective at inducing and maintaining remission in pediatric CD, yet there is no proven strategy for reducing exposure to medications once sustained remission has been achieved. Diet has been proven to impact disease activity in CD and may allow for sustained drug-free remission. The primary objective of this study is to determine whether pediatric CD patients in long-standing remission remain in remission longer after stopping medications if they follow the Crohn's Disease Exclusion Diet (CDED). The hypothesis is that subjects on the CDED will have longer time-to-relapse as opposed to those on an unrestricted diet.

Conditions

Interventions

TypeNameDescription
OTHERCrohn Disease Exclusion DietThe CDED is divided into 4 stages: 0-6 weeks induction phase, weeks 7-12 step down phase, weeks 13-24 maintenance phase I, and weeks 25-52 maintenance phase II.
OTHERFree DietThis diet contains no restrictions.

Timeline

Start date
2015-08-01
Primary completion
2019-05-01
Completion
2020-09-01
First posted
2015-06-15
Last updated
2020-10-20
Results posted
2020-05-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02472457. Inclusion in this directory is not an endorsement.